Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb 18;286(7):5876-83.
doi: 10.1074/jbc.M109.089607. Epub 2010 Dec 20.

ATP modulates interaction of syntaxin-1A with sulfonylurea receptor 1 to regulate pancreatic beta-cell KATP channels

Affiliations

ATP modulates interaction of syntaxin-1A with sulfonylurea receptor 1 to regulate pancreatic beta-cell KATP channels

Youhou Kang et al. J Biol Chem. .

Abstract

ATP-sensitive potassium (K(ATP)) channels are regulated by a variety of cytosolic factors (adenine nucleotides, Mg(2+), phospholipids, and pH). We previously reported that K(ATP) channels are also regulated by endogenous membrane-bound SNARE protein syntaxin-1A (Syn-1A), which binds both nucleotide-binding folds of sulfonylurea receptor (SUR)1 and 2A, causing inhibition of K(ATP) channel activity in pancreatic islet β-cells and cardiac myocytes, respectively. In this study, we show that ATP dose-dependently inhibits Syn-1A binding to SUR1 at physiological concentrations, with the addition of Mg(2+) causing a decrease in the ATP-induced inhibitory effect. This ATP disruption of Syn-1A binding to SUR1 was confirmed by FRET analysis in living HEK293 cells. Electrophysiological studies in pancreatic β-cells demonstrated that reduced ATP concentrations increased K(ATP) channel sensitivity to Syn-1A inhibition. Depletion of endogenous Syn-1A in insulinoma cells by botulinum neurotoxin C1 proteolysis followed by rescue with exogenous Syn-1A showed that Syn-1A modulates K(ATP) channel sensitivity to ATP. Thus, our data indicate that although both ATP and Syn-1A independently inhibit β-cell K(ATP) channel gating, they could also influence the sensitivity of K(ATP) channels to each other. These findings provide new insight into an alternate mechanism by which ATP regulates pancreatic β-cell K(ATP) channel activity, not only by its direct actions on Kir6.2 pore subunit, but also via ATP modulation of Syn-1A binding to SUR1.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
ATP dose-dependently inhibited Syn-1A binding to SUR1. GST-Syn-1A bound to glutathione-agarose beads was used to pull down SUR1 from SUR1/Kir6.2 expressing HEK293 cell lysate extract in the presence of increasing concentrations of ATP along with (A) or without (B) 2 mm MgCl2. The top panels in A and B show representative blots, and the bottom panels are the summaries of quantitative densitometry scanning of the specific bands. Free [ATP], free [Mg2+], and [MgATP] were calculated and shown on the top of the representative blot in B. The value from the assay in the absence of ATP and MgCl2 was considered as 100% (control). The results are expressed as mean ± S.E. (n = 3). The arrows in B point to the ATP concentrations (0.5 and 2 mm, respectively) which were used in the FRET study (Fig. 2).
FIGURE 2.
FIGURE 2.
ATP inhibited Syn-1A interaction with SUR1 in living cells. Shown in A (ia), A (iia), and A (iiia) are representative recordings of the FRET signals on the membrane of a same HEK cell expressing Syn-1A-mCherry, SUR1-EGFP, and Kir6.2 prior to (A, ia) and after addition of 0.5 (A, iia) and then 2 mm ATP (A, iiia), each for 3 min. The excitation wavelength was 488 nm, and fluorescence emission was measured at 605–655 nm. The arrows indicate the area where FRET signals decreased significantly after applying ATP. The bar indicates 5 μm. A (ib), A (iib), and A (iiib), the FRET efficiency in the same cell corresponding to A (ia), A (iia), and A (iiia), respectively. The vertical scale bar indicates the FRET efficiency in pseudocolor. A (iva) and A (ivb), FRET signal recording and efficiency in control cells expressing EGFP and mCherry. B, summary of FRET efficiency before and after addition of 0.5 or 2 mm ATP. ***, p < 0.001 compared with 0 ATP (n = 12). NS, no significant difference.
FIGURE 3.
FIGURE 3.
Syn-1A inhibited rat islet β-cell KATP currents in the presence of 0.3 but not 1 mm intracellular ATP. Cells were treated with 1 μm Syn-1A or 1 μm GST under whole-cell patch clamp recording mode. A, time course of KATP currents recorded in the presence of 0.3 mm intracellular MgATP. KATP currents were confirmed by application of 300 μm tolbutamide as indicated by arrows. B, time course of KATP currents in the presence of 1.0 mm intracellular MgATP. C, summary of the results. The maximum current magnitude was normalized with cell size to yield current density (pA/pF). *, significant difference compared with the control (p < 0.05). Results are expressed as mean ± S.E. (n = 6–11).
FIGURE 4.
FIGURE 4.
KATP channel sensitivity to Syn-1A inhibition is enhanced at lower but not at higher ATP concentration in endogenous Syn-1A-depleted cells. A, Western blotting analysis of Syn-1A expression in HEK293 cells transfected with Syn-1A or co-transfected with Syn-1A plus BoNT/C1 (Ai), and in INS-1E cells transfected with BoNT/C1 (Aii), as indicated. The cells were transfected with empty vector as a control. B–D, electrophysiological study. Effects of Syn-1A (0.3 μm) on KATP channels at various concentrations of ATP were examined. 0.3 μm GST was used as a negative control. Bi and Di, representative traces obtained from INS-1E cells transfected with EGFP alone. Ci and Dii, representative traces from INS-1E cells co-transfected with BoNT/C1 and EGFP. Bii and Cii, summary of results presented as means ± S.E. (n = 4). The differences (Δ) in current amplitude between application of GST and Syn-1A were calculated as a percentage of the maximal current (Imax) of each individual patch. *, p < 0.05.

Similar articles

Cited by

References

    1. Inagaki N., Tsuura Y., Namba N., Masuda K., Gonoi T., Horie M., Seino Y., Mizuta M., Seino S. (1995) J. Biol. Chem. 270, 5691–5694 - PubMed
    1. Suzuki M., Sasaki N., Miki T., Sakamoto N., Ohmoto-Sekine Y., Tamagawa M., Seino S., Marbán E., Nakaya H. (2002) J. Clin. Invest. 109, 509–516 - PMC - PubMed
    1. Tarasov A. I., Girard C. A., Ashcroft F. M. (2006) Diabetes 55, 2446–2454 - PubMed
    1. Hou J. C., Min L., Pessin J. E. (2009) Vitam. Horm. 80, 473–506 - PMC - PubMed
    1. Clement J. P., 4th, Kunjilwar K., Gonzalez G., Schwanstecher M., Panten U., Aguilar-Bryan L., Bryan J. (1997) Neuron 18, 827–838 - PubMed

Publication types

MeSH terms

LinkOut - more resources